Taro Pharmaceutical (DE:TAL)
BERLIN:TAL
Holding DE:TAL?
Track your performance easily

Taro Pharmaceutical (TAL) Ownership - Who Owns Taro Pharmaceutical?

0 Followers

Taro Pharmaceutical (TAL) Ownership Overview

0.00%0.00%3.85%96.15%
0.00%
Insiders
3.85% Other Institutional Investors
96.15% Public Companies and
Individual Investors
The ownership structure of Taro Pharmaceutical (DE:TAL) stock is a mix of institutional, retail and individual investors. Approximately 3.85% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 96.15% is owned by Public Companies and Individual Investors.
The ownership structure of Taro Pharmaceutical (DE:TAL) stock is a mix of institutional, retail and individual investors. Approximately 3.85% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 96.15% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024
xxxxxxxxxxxxx
$2135883
Mar 31, 2024
xxxxxxxxxxxxx
$12021045

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
40,216Institution1,723,698
4,723Institution202,433
4,509Institution193,260
283,917Institution0.00%12,168,967
223,542Institution0.00%9,581,234
50,446Institution0.00%2,162,166
1,757Institution75,307
12,332Institution528,562
204,592Institution8,769,018
32,500Institution1,392,983

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,757Institution75,307
12,332Institution528,562
204,592Institution8,769,018
32,500Institution1,392,983
383Institution16,416
56,780Institution2,433,648
710Institution30,431
14,800Institution634,343
1Institution43
80,870Institution3,466,169

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Taro Pharmaceutical (DE:TAL)?
According to the latest TipRanks data, approximately 3.85% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 96.15% is held by retail investors.
    What percentage of Taro Pharmaceutical (DE:TAL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 3.85% of Taro Pharmaceutical (DE:TAL) stock is held by institutional investors.
      What percentage of Taro Pharmaceutical (DE:TAL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 96.15% of Taro Pharmaceutical (DE:TAL) stock is held by retail investors.
        Who owns the most shares of Taro Pharmaceutical (DE:TAL)?
        Vanguard owns the most shares of Taro Pharmaceutical (DE:TAL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis